Noninvasive carcinoma of the breast: Angiogenesis and cell proliferation

Archives of Pathology and Laboratory Medicine

Volumn 128, Issue 8, 2004, Pages 893-896

  Cao, Ying ^a   Paner, Gladell P ^a   Kahn, Leonard B ^b   Rajan, Prabha B ^a,b  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; KI 67 ANTIGEN; TUMOR MARKER;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; BREAST DUCT; BREAST DUCTAL CARCINOMA IN SITU; BREAST LOBULAR CARCINOMA IN SITU; CANCER GRADING; CAPILLARY DENSITY; CARCINOMA IN SITU; CELL NUCLEUS; CELL PROLIFERATION; CELL PROLIFERATION INDEX; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROSCOPY; NONINVASIVE BREAST CARCINOMA; PROGNOSIS; RANK SUM TEST; SCORING SYSTEM; STATISTICAL ANALYSIS; TISSUE FIXATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; CELL DIVISION; CELL NUCLEUS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MIDDLE AGED; MITOTIC INDEX; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; STAINING AND LABELING;

EID: 3543024494     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ernster VL, Barclay J, Kerlikowske K. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA. 1996;275:913-918.
2. Teo NB, Shoker BS, Jarvis C, Martin L, Sloane JP, Holcombe C. Vascular density and phenotype around ductal carcinoma in situ (DCIS) of the breast. Br J Cancer. 2002;86:905-911.
3. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1-8.
4. Offersen BV, Borre M, Overgaard J. Quantification of angiogenesis as a prognostic marker in human carcinomas: a critical evaluation of histopathological methods for estimation of vascular density. Eur J Cancer. 2003;39:881-890.
5. Bosari S, Lee AK, DeLellis RA, Wiley BD, Heatley GJ, Silverman LM. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol. 1992;23:755-761.
6. Toi M, Kashitani J, Tominaga T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer. 1993;55:371-374.
7. Jansen RL. MIB-1 labeling index is an independent prognostic marker in primary breast cancer. Br J Cancer. 1998;78:460.
8. Scholzen T. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182:311.
9. Jones S, Clark G, Koleszar S, et al. Low proliferative rate of invasive node-negative breast cancer predicts for a favorable outcome: a prospective evaluation of 669 patients. Breast Cancer. 2001;1:310-314.
10. Gonzalez-Vela MC, Garijo MF, Fernandez F, Val-Bernal JF. MIB1 proliferation index in breast infiltrating carcinoma: comparison with other proliferative markers and association with new biological prognostic factors. Histol Histopathol. 2001;16:399-406.
11. Obermair A, Kurtz C, Czerwenka K, et al. Microvessel density and vessel invasion in lymph-node negative breast cancer: effect on recurrence free survival. Int J Cancer. 1995;62:126-131.
12. Bevilacqua P, Barbareschi M, Verderio P, et al. Prognostic value of intra-tumoral microvessel density, a measure of tumour angiogenesis, in node negative breast carcinoma: results of a multiparametric study. Breast Cancer Res Treat. 1995;36:205-217.
13. Costello P, McCann A, Carney DN, Dervan PA. Prognostic significance of microvessel density in lymph node negative breast carcinoma. Hum Pathol. 1995;26:1196-2000.
14. Ogawa Y, Chung YS, Nakata ST, et al. Microvessel quantitation in invasive breast cancer by staining for factor-VIII-related antigen. Br J Cancer. 1995;71:1297-1301.
15. Goulding H, Abdul Rashid NF, Robertson JF, et al. Assessment of angiogenesis in breast carcinoma: an important factor in prognosis? Hum Pathol. 1995;26:1196-1200.
16. Zolota V, Gerekosta A, Melachrinou M, Kominea A, Aletra C, Scopa CD. Microvessel density, proliferation activity, p53 and bcl-2 expression in in situ ductal carcinoma of the breast. Anticancer Res. 1999;19:3269-3274.
17. Aranda FI, Laforga JB. Cellular proliferation in breast ductal infiltrating carcinoma: correlation with clinical and histopathological variables. Pathol Res Pract. 1997;193:683-688.
18. Imamura H, Haga S, Shimizu T, Watanabe O, Kajiwara T, Aiba M. Prognostic significance of MIB1-determined proliferative activities in intraductal components and invasive foci associated with invasive ductal breast carcinoma. Br J Cancer. 1999;79:172-178.
19. Barbareschi M, Girlando S, Mauri FM, et al. Quantitative growth fraction evaluation with MIB1 and Ki67 antibodies in breast carcinomas. Am J Clin Pathol. 1994;102:171-175.